William Plovanic
Stock Analyst at Canaccord Genuity
(1.53)
# 3,320
Out of 4,376 analysts
635
Total ratings
40.7%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PLSE Pulse Biosciences | Initiated Coverage: Buy | $32 | $25.24 | +26.78% | 1 | Jun 4, 2026 | |
| PEN Penumbra | Maintained: Hold | $374 | $320.53 | +16.68% | 30 | Jun 2, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $71 → $70 | $48.55 | +44.18% | 41 | Jun 1, 2026 | |
| IRTC iRhythm Holdings | Maintained: Buy | $180 → $152 | $108.09 | +40.63% | 34 | Jun 1, 2026 | |
| DXCM DexCom | Reiterated: Buy | $100 → $82 | $72.86 | +12.54% | 44 | May 19, 2026 | |
| HTFL HeartFlow | Maintained: Buy | $43 → $37 | $28.10 | +31.67% | 12 | May 15, 2026 | |
| TLSI TriSalus Life Sciences | Maintained: Buy | $7 | $3.17 | +120.82% | 18 | May 13, 2026 | |
| CVRX CVRx, Inc. | Reiterated: Buy | $10 | $5.38 | +85.87% | 37 | May 12, 2026 | |
| CBLL CeriBell | Reiterated: Buy | $28 → $25 | $18.25 | +36.99% | 13 | May 12, 2026 | |
| AORT Artivion | Reiterated: Buy | $48 → $36 | $20.12 | +78.93% | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $124 | $69.43 | +78.60% | 53 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $19.34 | +80.97% | 13 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $435 → $249 | $153.22 | +62.51% | 43 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $23 | $8.00 | +187.50% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 → $55 | $27.10 | +102.95% | 35 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 → $400 | $305.66 | +30.86% | 23 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $5 | $1.53 | +226.80% | 11 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $87 → $85 | $85.96 | -1.12% | 38 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $1.29 | +132.56% | 30 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 → $79 | $80.00 | n/a | 20 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $25 | $15.12 | n/a | 3 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $19 | $11.94 | n/a | 10 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $42.80 | n/a | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $150 → $131 | $87.33 | n/a | 14 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3.66 → $7 | $9.04 | n/a | 2 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $32 | $30.61 | n/a | 6 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $23.78 | n/a | 1 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $48 → $43 | $29.99 | n/a | 17 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $86 → $70 | $64.48 | n/a | 17 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.28 | n/a | 7 | Feb 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.74 | n/a | 11 | Jan 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $7.01 | n/a | 6 | Nov 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $22 | - | n/a | 7 | Jul 29, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0002 | n/a | 6 | Feb 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $73 → $63 | $72.36 | n/a | 7 | Jun 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $14 | $7.35 | n/a | 4 | Jul 31, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $10.29 | n/a | 1 | Sep 9, 2011 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.99 | n/a | 1 | Jun 28, 2011 |
Pulse Biosciences
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $25.24
Upside: +26.78%
Penumbra
Jun 2, 2026
Maintained: Hold
Price Target: $374
Current: $320.53
Upside: +16.68%
Boston Scientific
Jun 1, 2026
Reiterated: Buy
Price Target: $71 → $70
Current: $48.55
Upside: +44.18%
iRhythm Holdings
Jun 1, 2026
Maintained: Buy
Price Target: $180 → $152
Current: $108.09
Upside: +40.63%
DexCom
May 19, 2026
Reiterated: Buy
Price Target: $100 → $82
Current: $72.86
Upside: +12.54%
HeartFlow
May 15, 2026
Maintained: Buy
Price Target: $43 → $37
Current: $28.10
Upside: +31.67%
TriSalus Life Sciences
May 13, 2026
Maintained: Buy
Price Target: $7
Current: $3.17
Upside: +120.82%
CVRx, Inc.
May 12, 2026
Reiterated: Buy
Price Target: $10
Current: $5.38
Upside: +85.87%
CeriBell
May 12, 2026
Reiterated: Buy
Price Target: $28 → $25
Current: $18.25
Upside: +36.99%
Artivion
May 11, 2026
Reiterated: Buy
Price Target: $48 → $36
Current: $20.12
Upside: +78.93%
May 11, 2026
Maintained: Buy
Price Target: $124
Current: $69.43
Upside: +78.60%
May 8, 2026
Maintained: Buy
Price Target: $35
Current: $19.34
Upside: +80.97%
May 7, 2026
Maintained: Buy
Price Target: $435 → $249
Current: $153.22
Upside: +62.51%
May 6, 2026
Reiterated: Buy
Price Target: $25 → $23
Current: $8.00
Upside: +187.50%
May 6, 2026
Maintained: Buy
Price Target: $53 → $55
Current: $27.10
Upside: +102.95%
May 1, 2026
Reiterated: Buy
Price Target: $300 → $400
Current: $305.66
Upside: +30.86%
Apr 30, 2026
Reiterated: Buy
Price Target: $20 → $5
Current: $1.53
Upside: +226.80%
Apr 24, 2026
Maintained: Hold
Price Target: $87 → $85
Current: $85.96
Upside: -1.12%
Apr 6, 2026
Maintained: Buy
Price Target: $3
Current: $1.29
Upside: +132.56%
Jan 22, 2024
Maintained: Buy
Price Target: $71 → $79
Current: $80.00
Upside: n/a
Jan 22, 2024
Maintained: Buy
Price Target: $24 → $25
Current: $15.12
Upside: n/a
Dec 21, 2023
Maintained: Buy
Price Target: $17 → $19
Current: $11.94
Upside: n/a
Dec 21, 2023
Maintained: Buy
Price Target: $15
Current: $42.80
Upside: n/a
Dec 15, 2023
Maintained: Hold
Price Target: $150 → $131
Current: $87.33
Upside: n/a
Dec 7, 2023
Upgraded: Buy
Price Target: $3.66 → $7
Current: $9.04
Upside: n/a
Nov 30, 2023
Maintained: Hold
Price Target: $32
Current: $30.61
Upside: n/a
Nov 7, 2023
Maintained: Buy
Price Target: $65
Current: $23.78
Upside: n/a
Sep 15, 2023
Maintained: Hold
Price Target: $48 → $43
Current: $29.99
Upside: n/a
Aug 28, 2023
Maintained: Hold
Price Target: $86 → $70
Current: $64.48
Upside: n/a
Feb 2, 2016
Maintained: Buy
Price Target: $8
Current: $1.28
Upside: n/a
Jan 11, 2016
Reiterated: Buy
Price Target: $12
Current: $3.74
Upside: n/a
Nov 5, 2015
Maintained: Buy
Price Target: $16
Current: $7.01
Upside: n/a
Jul 29, 2015
Reiterated: Hold
Price Target: $25 → $22
Current: -
Upside: n/a
Feb 2, 2015
Reiterated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Jun 5, 2014
Maintained: Buy
Price Target: $73 → $63
Current: $72.36
Upside: n/a
Jul 31, 2013
Reiterated: Hold
Price Target: $17 → $14
Current: $7.35
Upside: n/a
Sep 9, 2011
Maintained: Buy
Price Target: $45
Current: $10.29
Upside: n/a
Jun 28, 2011
Reiterated: Buy
Price Target: n/a
Current: $16.99
Upside: n/a